M. G. Rinaldi

J. Fung, P. Linden, M. Rinaldi, 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.

M G Rinaldi, J. Wingard, J. Karp, 1991, The New England journal of medicine.

Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey.

L. Saiman, R. Wenzel, M. Pfaller, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients

J. Wingard, J. Karp, W. Merz, 1993, Antimicrobial Agents and Chemotherapy.

Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

M. Ghannoum, J. Rex, T. Walsh, 2006, Journal of Clinical Microbiology.

Elucidating the Origins of Nosocomial Infections with Candida albicans by DNA Fingerprinting with the Complex Probe Ca3

L. Saiman, D. Soll, R. Wenzel, 1999, Journal of Clinical Microbiology.

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Labora

M. Ghannoum, J. Galgiani, J. Rex, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field gel electrophoresis.

M. Del Poeta, M. Pfaller, M. Rinaldi, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species.

M. A. Martin, L. Saiman, R. Wenzel, 1998, Diagnostic microbiology and infectious disease.

Resistance of Candida species to fluconazole

J. Rex, M. Pfaller, M. Rinaldi, 1995, Antimicrobial agents and chemotherapy.

Mycoses caused by Candida lusitaniae.

T. Hadfield, R. Winn, M. Rinaldi, 1987, Reviews of infectious diseases.

Evaluation of Possible Correlations between Antifungal Susceptibilities of Filamentous Fungi In Vitro and Antifungal Treatment Outcomes in Animal Infection Models

M. Ghannoum, J. Rex, T. Walsh, 1998, Antimicrobial Agents and Chemotherapy.

Collaborative investigation of variables in susceptibility testing of yeasts

J. Galgiani, M. Pfaller, R. Fromtling, 1990, Antimicrobial Agents and Chemotherapy.

Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infection

M. Pfaller, S. Redding, S. Messer, 1997, Journal of clinical microbiology.

A Head-on Comparison of the In Vitro Antifungal Activity of Conventional and Lipid-based Amphotericin B: a Multicenter Study

M. Ghannoum, M. Pfaller, S. Messer, 2000, Journal of chemotherapy.

Multicenter Comparison of the VITEK 2 Yeast Susceptibility Test with the CLSI Broth Microdilution Reference Method for Testing Fluconazole against Candida spp

M. Pfaller, G. Procop, D. Diekema, 2007, Journal of Clinical Microbiology.

Dermatophytosis: Epidemiological and microbiological update

M. Rinaldi, M. G. Rinaldi, 2000 .

Treatment of mycotic rhinitis with itraconazole in three horses.

P. Y. Wan, M. Rinaldi, A. Legendre, 1994, Journal of veterinary internal medicine.

Invasive Mycotic Infections Caused by Chaetomium perlucidum, a New Agent of Cerebral Phaeohyphomycosis

J. Guarro, R. Veve, M. Rinaldi, 2003, Journal of Clinical Microbiology.

Itraconazole treatment of phaeohyphomycosis.

R. M. Tucker, P. Hoeprich, D. Stevens, 1990, Journal of the American Academy of Dermatology.

Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole

A. Casadevall, M. Rinaldi, D. Webb, 1993, Antimicrobial Agents and Chemotherapy.

Multicenter evaluation of four methods of yeast inoculum preparation

M. Pfaller, M. Rinaldi, M. Bartlett, 1988, Journal of clinical microbiology.

Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients

Scott B. Johnson, M. Rech, J. Jorgensen, 2000, Transplant infectious disease : an official journal of the Transplantation Society.

In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans

V. Yu, M. Rinaldi, M. Nguyen, 1995, Antimicrobial agents and chemotherapy.

Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis

R. Allendoerfer, J. Graybill, M. Rinaldi, 1991, Antimicrobial Agents and Chemotherapy.

Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS

A. Berry, J. Graybill, M. Rinaldi, 1992, Antimicrobial Agents and Chemotherapy.

Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations.

R. M. Tucker, D. Denning, D. Stevens, 1990, Journal of the American Academy of Dermatology.

Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations.

R. M. Tucker, D. Denning, D. Stevens, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Candida krusei, a Multidrug-Resistant Opportunistic Fungal Pathogen: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005

R. Barton, M. Pfaller, D. Diekema, 2007, Journal of Clinical Microbiology.

Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients.

S. Redding, M. Rinaldi, T. Patterson, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients.

S. Redding, M. Rinaldi, T. Patterson, 1996, The Journal of infectious diseases.

In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus

A. Fothergill, A. Colombo, F. Barchiesi, 1994, Antimicrobial Agents and Chemotherapy.

Treatment of blastomycosis with itraconazole in 112 dogs.

B. Rohrbach, M. Rinaldi, A. Legendre, 1996, Journal of veterinary internal medicine.

Molecular Phylogeny and Proposal of Two New Species of the Emerging Pathogenic Fungus Saksenaea

J. Guarro, F. Dromer, A. Stchigel, 2010, Journal of Clinical Microbiology.

Microdilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: an eight-center collaborative study

E. Anaissie, M. Larocco, J. Galgiani, 1996, Antimicrobial agents and chemotherapy.

Antifungal susceptibility testing.

J. Galgiani, J. Rex, M. Pfaller, 2006, Infectious disease clinics of North America.

Epidemiology of Oropharyngeal CandidaColonization and Infection in Patients Receiving Radiation for Head and Neck Cancer

C. W. Bailey, R. Zellars, J. Lopez-Ribot, 1999, Journal of Clinical Microbiology.

Quality Control and Reference Guidelines for CLSI Broth Microdilution Susceptibility Method (M38-A Document) for Amphotericin B, Itraconazole, Posaconazole, and Voriconazole

M. Ghannoum, W. Schell, T. Walsh, 2005, Journal of Clinical Microbiology.

The epidemiology of non-albicans Candida in oropharyngeal candidiasis in HIV patients.

S. Redding, M. Rinaldi, T. Patterson, 2000, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.

Trichosporon beigelii, an emerging pathogen resistant to amphotericin B

T. Walsh, P. Pizzo, M. Rinaldi, 1990, Journal of clinical microbiology.

Invasive Nattrassia mangiferae infections: case report, literature review, and therapeutic and taxonomic appraisal

J. Galgiani, R. Summerbell, M. Rinaldi, 1997, Journal of clinical microbiology.

Intra- and Interlaboratory Study of a Method for Testing the Antifungal Susceptibilities of Dermatophytes

M. Ghannoum, M. Pfaller, M. Rinaldi, 2004, Journal of Clinical Microbiology.

Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii

J. Peter, T. Walsh, P. Pizzo, 1995, Antimicrobial agents and chemotherapy.

Electrophoretic karyotype and in vitro antifungal susceptibility of Cryptococcus neoformans isolates from AIDS patients.

M. Pfaller, S. Messer, M. Rinaldi, 1995, Diagnostic microbiology and infectious disease.

Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi

J. Rex, J. Peter, T. Walsh, 1997, Journal of clinical microbiology.